Anish Bhatnagar's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Dec 13, 2023
- Accession no.
- 0001209191-23-058577
- Filed
- Dec 13, 2023
- Trade date
- Dec 11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.33M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anish BhatnagarCIK 0001614821 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | SSaleDisposed | −51,205 | $35.26 | −$1,805,488.3 | 66,500 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −35,272 | $36.00 | −$1,269,792 | 31,228 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −6,931 | $37.01 | −$256,516.31 | 24,297 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.